Potential Risk to Blood Supply Probed

UPDATE: A followup article in the WSJ on Thursday, April 8th.


From The Wall Street Journal today (Monday 5, 2010):

Potential Risk to Blood Supply Probed

We are leaving thoughtful comments. A pretty well rounded article, but they (Mass media) continue to use the word "Replication" instead of "Validation". The difference is night and day in the biomedical world. The Whittemore Peterson Institute explains why here:

February 18, 2010: WPI is aware of the recent UK study that was unable to detect the presence of XMRV in any CFS patient samples.

Reading it again, I do think they spelled out the fact why the replications may not have worked. kudos wsj. I wish my brain would pick up these things the first time around. 

"Labs in Europe reported earlier this year that they haven't been able to replicate the XMRV findings in patients with chronic fatigue syndrome or prostate cancer. And public-health experts say a key issue in sorting out the disparate findings is to reach agreement on tests that are sensitive and reliable in identifying XMRV in the blood."

˙·٠•●♥ ƹ̵̡ӝ̵̨̄ʒ ♥●•٠·˙